STRAUMANN EMDOGAIN 075.114

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05 report with the FDA on 2013-11-08 for STRAUMANN EMDOGAIN 075.114 manufactured by Biora Ab.

Event Text Entries

[3983521] According to the information provided on (b)(6) 2013 the customer reports that they had an issue with a patient recently treated with emdogain. The patient developed a sort of cutaneous reaction whose origin cannot be detected. The clinician requested a technical sheet of emdogain reporting technical specifications of the product, sterilization etc. Based on the telephone conversation between stit complaint handling and the customer on (b)(6) 2013 additional information was requested. The customer used article 075. 114 emdogain 0. 3ml multipack lot number ea593. The surgery using emdogain and prefgel was carried out in (b)(6) on (b)(6) 2012. The event date is (b)(6) 2012. The customer reports there was swelling and inflammation. We presume that the prefgel used also came from the article 075. 114 lot ea593. The clinician provided additional information on (b)(6) 2013. The clinician reports that the patient has a bulge. No treatment has been administered to the patient as the clinician has to investigate the reasons of the reaction.
Patient Sequence No: 1, Text Type: D, B5


[11456692] Material safety data sheet was sent to customer as requested. The risk management report "risk mgmt report_emdogain-prefgel_v3" has identified that the use of emdogain in patients with compromised health conditions or in patients pre-disposed to allergic reactions might result in a body reaction (e. G. Allergic reaction) and is reflected in the eu ifu labelling 70016 / 701354. This labelling states that the "straumann product must be used in accordance with the instructions for use provided by the manufacturer. It is the practioner's responsibility to use the device in accordance with these instructions for use and to determine if the device fits to the individual patient situation. " the manufacturer reviewed manufacturing batch records for 075. 114 lot ea593 which contains emdogain batch ch476b and prefgel batch ae811. All products were released according to specifications. Review of the complaints database also confirmed that no further complaints have been reported with this article and lot number.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1222315-2013-00004
MDR Report Key3530571
Report Source01,05
Date Received2013-11-08
Date of Report2013-11-08
Date of Event2012-12-01
Date Mfgr Received2013-10-11
Device Manufacturer Date2011-09-01
Date Added to Maude2014-01-07
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationDENTIST
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactBERNIE MCDONALD
Manufacturer Street60 MINUTEMAN RD.
Manufacturer CityANDOVER MA 01810
Manufacturer CountryUS
Manufacturer Postal01810
Manufacturer Phone9787472514
Manufacturer G1BIORA AB
Manufacturer StreetMEDEON SCIENCE PARK
Manufacturer CityMALMO
Manufacturer CountrySW
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameSTRAUMANN EMDOGAIN
Generic NameBIOLOGIC MATERIAL, DENTAL
Product CodeNQA
Date Received2013-11-08
Catalog Number075.114
Lot NumberEA593
Device Expiration Date2013-09-30
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerBIORA AB
Manufacturer AddressMALMO SW


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2013-11-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.